ArticleCureus2026
Beyond Primary Epilepsy: Fahr's Syndrome Secondary to Congenital Parathyroid Agenesis Presenting With Generalised Seizures in a Young Adult.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Symmetrical, bilateral intracranial calcifications, commonly involving the basal ganglia, constitute the characteristic features of Fahr's syndrome, which is an uncommon neurometabolic condition. Its incidence in conjunction with congenital parathyroid agenesis, however, has rarely been reported. The present case emphasises how crucial it is to identify the metabolic origins of intracranial calcification and differentiate Fahr's syndrome from primary familial brain calcification to prevent repeated neurological consequences through adequate therapy. A 26-year-old man with congenital absence of the parathyroid gland presented to the emergency department after a 10-minute generalised tonic-clonic seizure, preceded by twitching of the perioral muscles. Examination revealed continuous perioral twitching, drowsiness in the postictal state and a positive Chvostek sign. Although the serum 25-hydroxyvitamin D (25-OH vitamin D) level remained within the normal range (88 nmol/L), laboratory tests revealed severe hypocalcaemia (1.44 mmol/L), hyperphosphatemia (1.95 mmol/L) and undetectable parathyroid hormone (<0.1 pmol/L), supporting hypoparathyroidism as the underlying cause of his symptoms. Non-contrast computed tomography (CT) of the head demonstrated typical bilateral symmetric basal ganglia calcifications, consistent with Fahr's syndrome, and an electrocardiogram (ECG) revealed QT interval prolongation. Intravenous calcium, oral calcium supplements, and alfacalcidol were used to treat the patient; this led to the correction of hypocalcaemia, full resolution of neuromuscular symptoms and no more seizures while the patient was in the hospital. This case demonstrates the rare correlation between Fahr's syndrome and congenital parathyroid agenesis that manifests in early adulthood. It highlights how crucial it is to take reversible metabolic factors into account when young adults exhibit new-onset seizures. Adequate vitamin D stores alone cannot maintain calcium homeostasis in individuals with congenital hypoparathyroidism, as evidenced by the significant hypocalcaemia that developed despite normal vitamin D status due to lacking parathyroid hormone.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.